Nuvation Bio Statistics
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.80-0.01 (-0.26%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Nuvation Bio by the numbers
Nuvation Bio has a market capitalization of $1.34 billion based on 352.02M shares outstanding. With trailing EPS of $-0.39, Nuvation Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.9% below its 50-day average and 28.0% below its 200-day average.
Average daily trading volume is 5.24M shares, or about $19.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NUVB valuation vs. peer median
| Metric | NUVB | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.34B | $1.36B | -1% |
| Avg. volume | 5.24M | 821.59K | +538% |
Peer median across 8 companies: NBTX, PAHC, URGN, QURE, RAPP, INVA, ANAB, TYRA.
Valuation
- Market cap
- $1.34B
- Price / sales (latest FY)
- 21.33
- EPS (TTM)
- $-0.39
- Shares outstanding
- 352.02M
Price and trading
- Previous close
- 3.81
- Open
- 3.77
- Day range
- 3.72 – 3.91
- 52-week range
- 3.71 – 9.75
- 52-week change
- -45.64%
- Beta
- —
- Volume
- 6.85M
- Average volume
- 5.24M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.34B
- Forward Pe
- -47.50
- Eps
- -0.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.75
- Week52 Low
- 3.71
- Avg Volume
- 5.24M
- Shares Outstanding
- 352.02M
- Ma50
- 4.87
- Ma200
- 5.28
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -61.03%
- Pct From52w Low
- 2.43%